Page last updated: 2024-09-04

olmesartan and Hypertension, Renal

olmesartan has been researched along with Hypertension, Renal in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Higa, A; Hirano, H; Iseki, K; Kohagura, K; Shiohira, Y; Tokuyama, K; Toma, S; Ueda, S	1
Felder, RA; Hashimoto, S; Jose, PA; Sanada, H; Watanabe, T; Yatabe, J; Yatabe, MS; Yoneda, M	1
Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T; Yamamoto, H	1
Anraku, M; Gebicki, JM; Kadowaki, D; Kitamura, K; Maruyama, T; Otagiri, M; Tasaki, Y; Tomita, K; Wakamatsu, S	1
Kang, JJ; Meer, EJ; Peti-Peterdi, J; Sipos, A; Toma, I; Vargas, SL	1

Reviews

1 review(s) available for olmesartan and Hypertension, Renal

Article	Year
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials. Hypertension research : official journal of the Japanese Society of Hypertension, 2013, Volume: 36, Issue:4 Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan	2013

Article

Year

Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.

Hypertension research : official journal of the Japanese Society of Hypertension, 2013, Volume: 36, Issue:4

Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan

2013

Trials

2 trial(s) available for olmesartan and Hypertension, Renal

Article	Year
Olmesartan clinical trial in Okinawan patients under OKIDS (OCTOPUS) study: design and methods. Clinical and experimental nephrology, 2009, Volume: 13, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension, Renal; Imidazoles; Japan; Kidney Failure, Chronic; Renal Dialysis; Tetrazoles	2009
Effect of olmesartan on oxidative stress in hemodialysis patients. Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Blood Pressure; Female; Humans; Hypertension, Renal; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peroxides; Placebos; Renal Dialysis; Serum Albumin; Tetrazoles; Uremia	2007

Article

Year

Olmesartan clinical trial in Okinawan patients under OKIDS (OCTOPUS) study: design and methods.

Clinical and experimental nephrology, 2009, Volume: 13, Issue:2

Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension, Renal; Imidazoles; Japan; Kidney Failure, Chronic; Renal Dialysis; Tetrazoles

2009

Effect of olmesartan on oxidative stress in hemodialysis patients.

Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Blood Pressure; Female; Humans; Hypertension, Renal; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peroxides; Placebos; Renal Dialysis; Serum Albumin; Tetrazoles; Uremia

2007

Other Studies

2 other study(ies) available for olmesartan and Hypertension, Renal

Article	Year
Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II. American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Autocrine Communication; Cells, Cultured; Chelating Agents; Cytochalasin D; Egtazic Acid; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Hypertension, Renal; Imidazoles; Male; Mesangial Cells; MicroRNAs; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Nucleic Acid Synthesis Inhibitors; Oxidative Stress; Paracrine Communication; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tetrazoles; Vasoconstrictor Agents	2009
The collecting duct is the major source of prorenin in diabetes. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertension, Renal; Imidazoles; Immunohistochemistry; Juxtaglomerular Apparatus; Kidney Tubules, Collecting; Microscopy, Fluorescence; Quinacrine; Rats; Rats, Wistar; Renin; Tetrazoles; Trypsin; Vasoconstrictor Agents	2008

Article

Year

Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II.

American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:5

Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Autocrine Communication; Cells, Cultured; Chelating Agents; Cytochalasin D; Egtazic Acid; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Hypertension, Renal; Imidazoles; Male; Mesangial Cells; MicroRNAs; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Nucleic Acid Synthesis Inhibitors; Oxidative Stress; Paracrine Communication; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tetrazoles; Vasoconstrictor Agents

2009

The collecting duct is the major source of prorenin in diabetes.

Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:6

Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Division; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertension, Renal; Imidazoles; Immunohistochemistry; Juxtaglomerular Apparatus; Kidney Tubules, Collecting; Microscopy, Fluorescence; Quinacrine; Rats; Rats, Wistar; Renin; Tetrazoles; Trypsin; Vasoconstrictor Agents

2008